Literature DB >> 6824127

Immunization of mice against Leishmania donovani by subcutaneous injections of dead promastigotes.

T W Holbrook, J A Cook.   

Abstract

Mice immunized by a series of intravenous, intraperitoneal or subcutaneous injections of formalin-killed Leishmania donovani promastigotes with glucan, a beta 1, 3 polyglucose, exhibited a significant degree of resistance against subsequent infection with viable promastigotes. Intramuscular immunization was not effective. Immunization via subcutaneous injections of dead promastigotes simultaneously with glucan elicited protective resistance, positive skin test responsiveness before and after challenge and increased antipromastigote antibody levels. Injections of glucan alone induced a lesser degree of resistance against infection without significant skin test or humoral responsiveness. Injections of dead promastigotes alone elicited increased antibody levels but no skin test responsiveness or resistance against infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824127     DOI: 10.4269/ajtmh.1983.32.51

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.

Authors:  H A Harima; N F Mendes; E M Mamizuka; M Mariano
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

2.  Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice.

Authors:  Farhat Afrin; Ravindran Rajesh; Khairul Anam; Meenakshisundram Gopinath; Swati Pal; Nahid Ali
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.

Authors:  F Afrin; N Ali
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Immunogenicity of soluble and particulate antigens from Leishmania donovani: effect of glucan as an adjuvant.

Authors:  J A Cook; T W Holbrook
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes.

Authors:  J González; M F Araguth; N Yoshida
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.

Authors:  Nicole Zimara; Menberework Chanyalew; Abraham Aseffa; Ger van Zandbergen; Bernd Lepenies; Maximilian Schmid; Richard Weiss; Anne Rascle; Anja Kathrin Wege; Jonathan Jantsch; Valentin Schatz; Gordon D Brown; Uwe Ritter
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

7.  A review of adjuvants for Leishmania vaccine candidates.

Authors:  Joshua M Mutiso; John C Macharia; Michael M Gicheru
Journal:  J Biomed Res       Date:  2010-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.